← Leaderboards
Ryan Englander
University Of Connecticut Sch Of Med/Dnt
$161,206
Attributed
$161,206
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$161,206 · 1
By mechanism
F30$161,206 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Kevin P. Claffey$4,486,488
- Adam J Adler$6,337,232
- Marc F Hansen$4,114,656
- Anthony T. Vella$15,822,694
- Jonathan Boyd Parr$4,138,029
Others in their field
Other Rising Stars on “Alternative Splicing”
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Fergal James Martin · University Of California Santa Cruz$3,331,254
- Zachary Miles · Alida Biosciences, Inc.$2,512,331
- Qin Liu · Massachusetts Eye And Ear Infirmary$2,373,472
- Alisha Jones · New York University$2,129,028
- Bo Xia · Broad Institute, Inc.$1,909,873
Research focus
Alternative SplicingCodeAntigen TargetingAmino Acid SequenceAntigensAnti-Tumor Immune ResponseAutomobile DrivingBindingBinding SitesBioinformatics PipelineCancer CellCancer Cell LineCancer EtiologyCancer PatientCancer TypeCancer VaccinesCandidate IdentificationCareerCd8-Positive T-LymphocytesCellsCell SurfaceCessation Of LifeCoculture TechniquesCohort
Grant awards (3)
Alternate splicing as a source of shared neoantigens in a non-small cell lung cancer$54,538
F30 · FY2025 · CA · contact PI
Alternate splicing as a source of shared neoantigens in a non-small cell lung cancer$53,974
F30 · FY2024 · CA · contact PI
Alternate splicing as a source of shared neoantigens in a non-small cell lung cancer$52,694
F30 · FY2023 · CA · contact PI